PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 35 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

10 July 2025

  1. (diff | hist) m 14:09 Guangzhou JEEP Biotechnology 13,039 +810 BlankVialBo (talk | contribs) rm the adjective — an organisation article describes, it does not praise [rollback]
  2. (diff | hist) 13:17 Dipeptidyl peptidase-4 7,022 +554 AmylinAmos (talk | contribs) British spelling per PP:MOS [rollback]
  3. (diff | hist) m 11:46 SURMOUNT trial programme 4,572 ±0 Chromatokid (talk | contribs) add the trial registration identifier [rollback]
  4. (diff | hist) 10:15 Talk:Zhuhai Kerui Biotechnology 1,170 +142 FreightFenna (talk | contribs) /* Transit-time statements need a denominator */ reply
  5. (diff | hist) 03:35 Fasting insulin 3,910 ±0 SchemaSorcha (talk | contribs) add the units and the conversion factor to SI [rollback]
  6. (diff | hist) 03:20 Counterfeit peptide 4,235 ±0 LedgerLysander (talk | contribs) add the cross-link to the traceability article [rollback]
  7. (diff | hist) m 02:55 Shanghai Sigma-Audley New Material Technology 10,588 ±0 Retention_Time_Rae (talk | contribs) typo [rollback]
  8. (diff | hist) 02:54 Missed dose 5,031 ±0 UnderfillUna (talk | contribs) expand §The governing arithmetic [rollback]
  9. (diff | hist) m 02:38 Solid-phase peptide synthesis 5,359 ±0 Chromatokid (talk | contribs) fix the anchor on an internal link [rollback]
  10. (diff | hist) m 01:48 Regulatory status by jurisdiction 4,262 +32 GMP_Gita (talk | contribs) rm the claim that the position has changed; no source supports it [rollback]

9 July 2025

  1. (diff | hist) m 09:09 Zhuhai Kerui Biotechnology 5,385 +678 DiagramDelphine (talk | contribs) split §Operations from §Product range [rollback]
  2. (diff | hist) 08:47 Talk:Zhuhai Kerui Biotechnology 959 +234 CustomsClarke (talk | contribs) /* Transit-time statements need a denominator */ reply

8 July 2025

  1. (diff | hist) 23:52 Tianjin Finder Chemical 9,607 +639 GradientGus (talk | contribs) split §Operations from §Product range [rollback]
  2. (diff | hist) 18:39 Resin cleavage 4,029 ±0 MolarMassMaeve (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  3. (diff | hist) 17:43 Shanghai ERP Biotechnology 2,987 +1,264 ReportReaderRilla (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  4. (diff | hist) 16:41 Patent expiry and biosimilars 3,580 ±0 RedirectRini (talk | contribs) fix the anchor on an internal link [rollback]
  5. (diff | hist) 16:36 GL Biochem (Shanghai) 14,530 +226 Chromatokid (talk | contribs) attribute the capability claim to the organisation's own material [rollback]
  6. (diff | hist) 15:30 Talk:Zhuhai Kerui Biotechnology 748 +174 TallySheetTad (talk | contribs) /* Transit-time statements need a denominator */ reply
  7. (diff | hist) 13:54 Active pharmaceutical ingredient 3,779 +24 FiveOhThreeB (talk | contribs) correct the agency abbreviation at first use [rollback]
  8. (diff | hist) 11:28 Temperature excursion 11,765 +812 RepackRadek (talk | contribs) add the collapse-temperature point, sourced [rollback]
  9. (diff | hist) 11:02 Talk:Zhuhai Kerui Biotechnology 537 +276 FreightFenna (talk | contribs) /* Transit-time statements need a denominator */ new section
  10. (diff | hist) m b 07:14 Bachem Holding (Suzhou) 12,112 +271 StubSorterBot (talk | contribs) bot: mark outbound storefront link nofollow [rollback]

7 July 2025

  1. (diff | hist) 21:38 LEADER trial 4,171 ±0 PioneerPerdita (talk | contribs) the trial was open-label; the article implied blinding [rollback]
  2. (diff | hist) m 20:47 Glucagon-like peptide-1 12,102 +672 ReceptorRhoda (talk | contribs) add the enteroendocrine cell type responsible for secretion [rollback]
  3. (diff | hist) m b 13:52 Blind sampling 7,867 +558 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  4. (diff | hist) m 12:55 Survodutide 4,528 +18 INN_Ingrid (talk | contribs) give the INN alongside the trade name at first mention [rollback]
  5. (diff | hist) 08:58 Shanghai Wibson Biotechnology 8,684 +468 CustomsClarke (talk | contribs) add the catalogue size and label it self-reported [rollback]
  6. (diff | hist) 07:32 Certificate of analysis 9,449 +586 PurityClaimPia (talk | contribs) rm the ranking language; this wiki publishes no ranking [rollback]
  7. (diff | hist) m b 07:03 Contraindications of incretin therapy 4,842 +546 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  8. (diff | hist) 05:05 Qingdao Saber Technology Pharmaceutical 3,929 +696 DrTitration (talk | contribs) copyedit [rollback]
  9. (diff | hist) 03:17 Haemoglobin A1c 4,096 ±0 Peptide_Pete (talk | contribs) expand §Use in this field [rollback]
  10. (diff | hist) m 00:02 Glucagon 7,074 +455 SelectTrialSam (talk | contribs) add category for the drug class [rollback]

6 July 2025

  1. (diff | hist) m b 19:49 Drug master file 4,092 ±0 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  2. (diff | hist) m 19:09 STEP trial programme 5,251 +137 MTC_Marisol (talk | contribs) add the comparator arm — an event rate alone says nothing [rollback]
  3. (diff | hist) m 16:46 GLP-1 receptor agonist 9,922 +164 ComparisonCato (talk | contribs) copyedit [rollback]
  4. (diff | hist) m 12:37 Hunan Aslsen Technology 10,977 +335 Chromatokid (talk | contribs) state the city and province of the registered address [rollback]
  5. (diff | hist) m 09:00 Gastric emptying 5,258 ±0 EmptyingElke (talk | contribs) attribute the receptor-density claim to the tissue study it comes from [rollback]
  6. (diff | hist) m 03:28 Deamidation 4,961 +742 ColumnOvenCoy (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]
  7. (diff | hist) m b 02:10 Proglucagon 6,144 ±0 CiteBot (talk | contribs) bot: update parent category chain [rollback]

5 July 2025

  1. (diff | hist) 22:17 Purity claim inflation 5,175 +19 ShortDescShai (talk | contribs) clarify that a QR code on a certificate proves issuance, not content [rollback]
  2. (diff | hist) 04:11 Methionine oxidation 4,523 +673 ChromCleanupCass (talk | contribs) rm the vendor name from a methodological sentence [rollback]
  3. (diff | hist) m b 03:19 Reverse-phase HPLC 5,116 ±0 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  4. (diff | hist) 01:21 Reference standard 4,806 ±0 TechnicianTeal (talk | contribs) state the column chemistry and the gradient the figure was obtained on [rollback]
  5. (diff | hist) 00:14 Sarcopenia 3,762 ±0 eGFR_Esme (talk | contribs) add category for laboratory medicine [rollback]

4 July 2025

  1. (diff | hist) 23:03 Cost per milligram 3,292 ±0 TSH_Tallulah (talk | contribs) expand §Approved products [rollback]
  2. (diff | hist) 22:18 CagriSema 5,302 +1,117 CustomsClarke (talk | contribs) the storage condition applies to the unopened pen; say so [rollback]
  3. (diff | hist) 21:59 Karl Fischer titration 8,306 +357 Retention_Time_Rae (talk | contribs) add the reference standard and its traceability [rollback]
  4. (diff | hist) 19:30 Semaglutide 9,799 +1,239 GroupBuyGalen (talk | contribs) state the substitution in one-letter code as well, per PP:MOS [rollback]
  5. (diff | hist) 18:12 Liraglutide 5,815 +547 SemaglutideSasha (talk | contribs) split §Pharmacology into receptor binding and downstream signalling [rollback]
  6. (diff | hist) m 11:59 Fmoc chemistry 4,618 ±0 ForestPlotFinn (talk | contribs) attribute the stability figure to the study and its duration [rollback]
  7. (diff | hist) 09:14 Liquid chromatography-mass spectrometry 4,276 +534 DiagramDelphine (talk | contribs) state the titration endpoint and the reagent factor [rollback]
  8. (diff | hist) 04:18 Glossary of peptide terminology 4,744 ±0 GroupBuyGalen (talk | contribs) reconcile the list against the category; two articles were missing [rollback]

3 July 2025

  1. (diff | hist) 23:05 Xi'an Mokemei Biotechnology 7,195 +144 BlankVialBo (talk | contribs) close an unbalanced quotation mark [rollback]
  2. (diff | hist) 21:55 List of GLP-1 receptor agonists 3,631 ±0 ListMakerLumi (talk | contribs) correct an entry that duplicated the one above it [rollback]
  3. (diff | hist) 19:16 Preparative HPLC purification 4,882 +284 CrudePeptidePearl (talk | contribs) split §Cold chain from §Storage after receipt [rollback]
  4. (diff | hist) m 19:06 Shanghai ERP Biotechnology 1,723 ±0 LCellLeif (talk | contribs) clarify that no manufacturing or marketing authorisation is claimed or established [rollback]
  5. (diff | hist) 13:16 Trifluoroacetate counterion 3,918 ±0 GastroparesisGwen (talk | contribs) add category for method validation [rollback]
  6. (diff | hist) 09:40 Crude peptide 4,546 +608 FreightFenna (talk | contribs) give the closure integrity test by name [rollback]
  7. (diff | hist) 09:26 Talk:Peptide content 1,096 +103 ColumnOvenCoy (talk | contribs) /* Counterion by inference */ reply
  8. (diff | hist) 06:15 Beyond-use date 15,368 ±0 A1c_Alder (talk | contribs) expand §Sterile preparations under USP <797> [rollback]
  9. (diff | hist) 03:17 Grey market 3,461 ±0 SPPS_Sorrel (talk | contribs) expand §How goods leave authorised channels [rollback]
  10. (diff | hist) 00:08 Insulin syringe unit conversion 5,079 ±0 EscalationEira (talk | contribs) add the note that the result is a calculation, not a recommendation [rollback]

2 July 2025

  1. (diff | hist) m 22:34 Analytical method validation 5,342 +268 LedeLeander (talk | contribs) correct the flow rate — the source gives it in mL/min [rollback]
  2. (diff | hist) m 18:07 Baseline laboratory panel 4,222 ±0 Hedgerow_Hal (talk | contribs) expand §Why consistency matters more than completeness [rollback]
  3. (diff | hist) 15:08 Talk:Peptide content 885 +201 AAA_Analyst (talk | contribs) /* Counterion by inference */ reply
  4. (diff | hist) 11:34 Reconstitution calculator 7,641 +336 ResolutionRoo (talk | contribs) give the figures to a consistent number of significant figures [rollback]
  5. (diff | hist) m b 10:53 Incretin effect 7,134 +181 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  6. (diff | hist) 10:38 Talk:Vial 1,170 +80 StopperingSteff (talk | contribs) /* Overflow capacities in the R-series table */ reply
  7. (diff | hist) 10:33 Talk:Peptide content 674 +220 ColumnOvenCoy (talk | contribs) /* Counterion by inference */ new section
  8. (diff | hist) 09:37 Talk:Blind sampling 1,307 +125 GroupBuyGalen (talk | contribs) /* Anonymous ordering: does it count as blinding? */ reply
  9. (diff | hist) 09:15 Talk:Qingdao Saber Technology Pharmaceutical 822 +67 DisambigDenzil (talk | contribs) /* Two organisations, one city, similar names */ reply
  10. (diff | hist) N 09:00 Shanghai ERP Biotechnology 1,723 +1,723 LedgerLysander (talk | contribs) start organisation article — registry facts and product scope only
  11. (diff | hist) 05:21 Sterility testing 4,438 +775 Chromatokid (talk | contribs) close an unbalanced quotation mark [rollback]
  12. (diff | hist) 00:04 Injection site rotation 4,626 +562 eGFR_Esme (talk | contribs) correct the needle gauge given for subcutaneous administration [rollback]

1 July 2025

  1. (diff | hist) m 22:22 Prescribing information 4,364 ±0 AnalyticalAnnie (talk | contribs) fix indentation in the source [rollback]
  2. (diff | hist) 12:09 Triple agonist 3,987 ±0 CustomsClarke (talk | contribs) add see also to the amylin analogue [rollback]
  3. (diff | hist) m 09:37 Prior authorisation 3,517 ±0 PatientPanelPru (talk | contribs) state that the pricing data is self-reported where it is [rollback]
  4. (diff | hist) 09:03 Talk:Vial 959 +140 SigFigSindri (talk | contribs) /* Overflow capacities in the R-series table */ reply
  5. (diff | hist) 08:44 Talk:Blind sampling 1,096 +162 ChainCustodyChad (talk | contribs) /* Anonymous ordering: does it count as blinding? */ reply

30 June 2025

  1. (diff | hist) 22:28 Wuhan Wansheng Biotechnology 13,238 +1,017 SecondarySrc_Seb (talk | contribs) add the incorporation year, attributed to the registry record [rollback]
  2. (diff | hist) 18:06 Peptide synthesis 4,967 ±0 CDMO_Caradoc (talk | contribs) correct the freezer temperature range given for long-term storage [rollback]
  3. (diff | hist) 17:11 Talk:Vial 748 +325 StopperingSteff (talk | contribs) /* Overflow capacities in the R-series table */ reply
  4. (diff | hist) 16:48 Chinese Peptide Company 13,077 ±0 DiffWatchDov (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  5. (diff | hist) 15:54 Peptide content 8,131 +1,206 LiraLotte (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  6. (diff | hist) 14:55 Talk:Blind sampling 885 +194 BlindSampleBrid (talk | contribs) /* Anonymous ordering: does it count as blinding? */ reply
  7. (diff | hist) 14:26 Talk:Vial 537 +329 SigFigSindri (talk | contribs) /* Overflow capacities in the R-series table */ new section
  8. (diff | hist) 14:10 Customs seizure 3,672 +28 ImportPolicyIggy (talk | contribs) clarify that personal importation and commercial importation are different questions [rollback]
  9. (diff | hist) 13:27 Talk:Qingdao Saber Technology Pharmaceutical 611 +154 NPOV_Nadia (talk | contribs) /* Two organisations, one city, similar names */ reply
  10. (diff | hist) m 11:45 Zhuhai Kerui Biotechnology 4,707 +519 ForgeryFinder (talk | contribs) add the how-to-request-a-batch-record sentence to §Ordering and availability [rollback]
  11. (diff | hist) 11:21 Talk:Blind sampling 674 +129 GroupBuyGalen (talk | contribs) /* Anonymous ordering: does it count as blinding? */ new section
  12. (diff | hist) 10:55 Flourishglobal Peptide Biotech 7,208 +330 B12_Bettina (talk | contribs) label the reception tally as weak, self-selected evidence at this point of use [rollback]
  13. (diff | hist) 10:52 Talk:Qingdao Saber Technology Pharmaceutical 400 +224 DisambigDenzil (talk | contribs) /* Two organisations, one city, similar names */ new section
  14. (diff | hist) 07:25 Weight regain after discontinuation 4,624 ±0 GastroparesisGwen (talk | contribs) consistent en dashes in ranges [rollback]
  15. (diff | hist) 00:16 Contract development and manufacturing organisation 4,240 +24 RepackRadek (talk | contribs) state that a phase-change pack and a gel pack behave differently [rollback]

29 June 2025

  1. (diff | hist) m 22:52 Medutest 4,669 ±0 SecondarySrc_Seb (talk | contribs) close an unbalanced quotation mark [rollback]
  2. (diff | hist) m 19:35 Hubei Jianxiang Bioscience 7,002 +899 BatchNumberBede (talk | contribs) ce [rollback]
  3. (diff | hist) 08:41 WuXi TIDES 13,627 +1,712 BlankVialBo (talk | contribs) split overlong sentence [rollback]
  4. (diff | hist) m 02:58 Research use only 7,423 ±0 GsCouplingGil (talk | contribs) rm the speculation about future scheduling [rollback]
  5. (diff | hist) 01:38 Dose escalation schedule 4,096 +23 NurseNoteNessa (talk | contribs) correct the unit conversion — U-100 not U-40 [rollback]
  6. (diff | hist) 01:08 Dulaglutide 5,130 ±0 OralSemaOswin (talk | contribs) split §Pharmacology into receptor binding and downstream signalling [rollback]